Consistent with these results, STAT6-deficient BALB/C (BC.STAT6) mice, which are defective in IL-4 and IL-13 signaling, showed higher levels of iNOS+ CD11b+ CD11c+ cells, when compared to infected BC.WT mice (Figure 5C). This evidence concerns the gene STAT6 and breast cancer.